Caltech Develops System for Brain Drug Delivery

Caltech researchers developed 'BrainCAB,' a novel small-molecule system designed to transport therapeutic molecules across the blood-brain barrier. This preclinical technology utilizes a modified glaucoma drug as a molecular shuttle. Published in Nature Chemical Biology, it offers a promising new pathway for more effective treatment of neurological disorders.